Antiparasitic Tablets Albendazole Tablets Are Suitable for Internal and External Parasites in Animals

Name: Antiparasitic Tablets Albendazole Tablets Are Suitable for Internal and External Parasites in Animals
Brand: Handan Jiaxin Liupin Biotechnology Co., Ltd.
SKU: 2171727265

Hebei, ChinaHandan Jiaxin Liupin Biotechnology Co., Ltd.

US$0.11-0.63

1,000 Pieces

Sample price:US$10.00/piece.Request sample

Product profile

Varieties

Parasite Disease Prevention Medicine

Component

Chemical Synthetic Drugs

Pharmacodynamic Influential Factors

Combined Medication

Storage Method

Light Proof

Factory/Manufacturer

Yes

GMP

Yes

ISO

Yes

SGS

Yes

OEM/ODM

Yes

Transport Package

Carton/Wooden Box

Trademark

Tengmukeji

Origin

China

Production Capacity

50000 Boxs /Day

Company profile

Handan Jiaxin Liupin Biotechnology Co., Ltd.Hebei, China

Business Type: Manufacturer/FactoryExport Year: 2015-09-01Nearest Port: TianjinAverage Response Time: ≤24hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF

AI-Powered supplier vetting

SummaryHandan Jiaxin Liupin Biotechnology Co., Ltd. is a China-based manufacturer/factory in the veterinary medicine sector, founded in 2014 and located in Hebei. Its stated product range covers veterinary antibiotics, vaccines, antiparasitic drugs, nutritional supplements, injections, oral solutions, tablets, pills, and suspensions. The supplier reports ISO 9001 and GMP management-system certifications, 6–10 R&D engineers, and 6–10 quality-control staff. It has exported since 2015 and reports that exports account for 51%–70% of total sales, with self-operated import and export rights. The company states that it supports OEM customized production and maintains production quality controls. However, the provided information does not confirm current contract manufacturing status, inventory services, overseas warehouses, overseas showrooms or agents, after-sales support, financial credibility, customer cases, traceability, or specific innovation service capabilities. The SGS audit record is historical, covering...

Supplier typeThe supplier is explicitly identified as a Manufacturer/Factory in China and is described as a high-tech enterprise engaged in the R&D, production, and sale of veterinary drugs. Its stated product scope includes veterinary antibiotics, vaccines, antiparasitic drugs, nutritional supplements, injections, oral solutions, tablets, pills, and suspensions.

CertificationsThe supplier reports ISO 9001 and GMP certifications and states that it follows GMP standards for veterinary drugs. An SGS audit record is also provided, but its validity period ended on 2025-08-18, so the slices do not establish a currently valid audit result.

R&D capabilityThe company describes itself as a high-tech enterprise, reports cooperation with domestic and foreign research institutions, and identifies advanced research laboratories and 6–10 R&D engineers. However, ODM, SDK, private-mold, 3D design, and new-product development statuses are all unknown, so the breadth of formal innovation services cannot be confirmed.

Production capacityThe supplier is identified as a factory with high-standard production workshops and advanced production equipment, and it lists multiple veterinary injectable, oral, tablet, suspension, antibiotic, antiparasitic, and nutritional products. It also reports self-operated import and export rights and exports beginning in 2015. Nevertheless, the stated annual productivity field is incomplete because it gives only a product and unit without a quantity, while manufacturing-capacity contract status and raw-material traceability are unknown.

Customization capabilityThe supplier explicitly states that it supports OEM customized production from raw-material procurement through final packaging. OEM capability for popular brands and ODM service availability are separately marked unknown, so the evidence supports OEM customization but not a broader range of customization services.